Closed
NHS National Framework for Generics Orals, Non-Parenteral & Housekeeping
NHS England
- Value
- £518,739,710
- Published
- 21 Sept 2026
- Deadline
- 19 Oct 2026
- Procedure
- Open procedure
- Category
- 33600000 — Pharmaceutical products
- Location
- London, UKI45, SE1 8UG, United Kingdom
- Notice reference
- 089063-2026
Requirements summary
NHS England is running an open-procedure framework agreement for generic oral, non-parenteral and hospital housekeeping pharmaceutical products, split into two lots with a combined value of GBP 432.3m excluding VAT (GBP 518.7m gross). Lot 1 covers oral and non-parenteral products for regional call-offs from June 2027 for 36 months, and Lot 2 covers hospital-only products for regional call-offs of 12 to 28 months from June 2027. The tender closes on 19 October 2026.
Key requirements
- Supply of generic oral and non-parenteral pharmaceutical products under a framework agreement (Lot 1, GBP 281.8m excluding VAT)
- Supply of hospital-only oral, non-parenteral and housekeeping pharmaceutical products (Lot 2, GBP 150.5m excluding VAT)
- Regional call-off periods starting 1 June 2027, with durations of 12 to 36 months depending on region
- Framework may be extended at the authority's discretion, up to a maximum total of 48 months
- Additional offer schedule added for nintedanib 150mg and 100mg capsules and dalbavancin 500mg powder for infusion vials
- Tender submissions due by 19 October 2026 at 12:00 UTC, via the Health Family procurement portal; English language only
Similar open notices
- NHS National Framework Agreement for Macitentan & Cladribine TabletsNHS England
- NHS National Framework Agreement for Macitentan & Cladribine TabletsNHS England
- Injection Equipment ParaphernaliaThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy ServicesUniversity Hospitals of Derby and Burton NHS Foundation Trust
- NEYPPC Pharmacy - Unlicensed Imported Medicines (wave 2)Leeds Teaching Hospitals NHS Trust